BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9685211)

  • 1. Agonist-specific modulation of glucocorticoid receptor-mediated transcription by immunosuppressants.
    Medh RD; Lay RH; Schmidt TJ
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):11-23. PubMed ID: 9685211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands.
    Marsaud V; Mercier-Bodard C; Fortin D; Le Bihan S; Renoir JM
    J Steroid Biochem Mol Biol; 1998 Jul; 66(1-2):11-25. PubMed ID: 9712407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression.
    Renoir JM; Mercier-Bodard C; Hoffmann K; Le Bihan S; Ning YM; Sanchez ER; Handschumacher RE; Baulieu EE
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4977-81. PubMed ID: 7539138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters.
    Pariante CM; Makoff A; Lovestone S; Feroli S; Heyden A; Miller AH; Kerwin RW
    Br J Pharmacol; 2001 Nov; 134(6):1335-43. PubMed ID: 11704655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells.
    Ishizuka T; Sakata N; Johnson GL; Gelfand EW; Terada N
    Biochem Biophys Res Commun; 1997 Jan; 230(2):386-91. PubMed ID: 9016789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of glucocorticoid receptor-mediated gene expression by the immunophilin ligands FK506 and rapamycin.
    Ning YM; Sánchez ER
    J Biol Chem; 1993 Mar; 268(9):6073-6. PubMed ID: 7681058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor.
    Renoir JM; Le Bihan S; Mercier-Bodard C; Gold A; Arjomandi M; Radanyi C; Baulieu EE
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):101-10. PubMed ID: 7510997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity.
    Schaaf MJ; Cidlowski JA
    Mol Cell Biol; 2003 Mar; 23(6):1922-34. PubMed ID: 12612067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line.
    Schwaninger M; Blume R; Oetjen E; Knepel W
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):541-5. PubMed ID: 7509460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the glucocorticoid receptor subcellular localization by non steroidal compounds.
    Prima V; Depoix C; Masselot B; Formstecher P; Lefebvre P
    J Steroid Biochem Mol Biol; 2000; 72(1-2):1-12. PubMed ID: 10731632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin A and FK506 are potent activators of proopiomelanocortin-derived peptide secretion without affecting corticotrope glucocorticoid receptor function.
    Sheppard KE
    J Neuroendocrinol; 1995 Nov; 7(11):833-40. PubMed ID: 8748119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine a and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation.
    Deppe CE; Heering PJ; Viengchareun S; Grabensee B; Farman N; Lombès M
    Endocrinology; 2002 May; 143(5):1932-41. PubMed ID: 11956176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylalanine-780 near the C-terminus of the mouse glucocorticoid receptor is important for ligand binding affinity and specificity.
    Chen D; Kohli K; Zhang S; Danielsen M; Stallcup MR
    Mol Endocrinol; 1994 Apr; 8(4):422-30. PubMed ID: 8052263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
    Davies TH; Ning YM; Sánchez ER
    Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells.
    Edinger RS; Watkins SC; Pearce D; Johnson JP
    Am J Physiol Renal Physiol; 2002 Aug; 283(2):F254-61. PubMed ID: 12110508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones.
    Kralli A; Yamamoto KR
    J Biol Chem; 1996 Jul; 271(29):17152-6. PubMed ID: 8663352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclic AMP response element-binding protein/cyclic AMP response element-mediated transcription by the immunosuppressive drugs cyclosporin A and FK506 depends on the promoter context.
    Siemann G; Blume R; Grapentin D; Oetjen E; Schwaninger M; Knepel W
    Mol Pharmacol; 1999 Jun; 55(6):1094-100. PubMed ID: 10347253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists.
    Wilson VS; Bobseine K; Lambright CR; Gray LE
    Toxicol Sci; 2002 Mar; 66(1):69-81. PubMed ID: 11861974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiglucocorticoid, cortexolone, fails to promote in vitro activation of cytoplasmic glucocorticoid receptors from the human leukemic cell line CEM-C7.
    Schmidt TJ; Davidson CJ
    J Steroid Biochem; 1987 Mar; 26(3):329-36. PubMed ID: 3586649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.